Hepatorenal syndrome (HRS) is a serious complication of advanced liver disease, particularly cirrhosis, where kidney function declines due to reduced blood flow to the kidneys. It’s a rapidly progressive kidney failure that often leads to death if left untreated. HRS is characterized by functional renal failure without any damage to the kidney tissue itself.
Key points about hepatorenal syndrome:
Cause:
Advanced liver disease, especially cirrhosis, leading to reduced blood flow to the kidneys.
Mechanism:
Reduced blood flow to the kidneys impairs their ability to filter waste and maintain blood pressure.
Types:
Type 1: Rapid progression, poor prognosis, with a median survival time of 2 weeks.
Type 2: More gradual progression, better prognosis than type 1.
Symptoms:
May include abdominal swelling (ascites), decreased urine output, mental confusion, and jaundice.
Treatment:
Liver transplantation is the most effective treatment, but other medical treatments are also used.
Prognosis:
Without treatment, HRS has a very poor prognosis, with survival measured in weeks to months.

In hepatorenal syndrome, reduced blood flow to the kidneys occurs primarily due to renal vasoconstriction resulting from cirrhosis and related portal hypertension. This vasoconstriction is a compensatory mechanism triggered by a decrease in effective circulating volume due to splanchnic vasodilatation and fluid accumulation in the abdominal cavity (ascites).
Hepatorenal syndrome in children: a review | Pediatric …
Here’s a more detailed explanation:

1. Reduced Effective Circulating Volume:
   Cirrhosis and portal hypertension cause splanchnic vessels (in the gut) to dilate, leading to a decrease in the overall amount of blood in the body’s circulatory system, particularly in the arteries. This reduced blood volume, though total blood volume may be normal, is known as effective hypovolemia.
2. Renal Vasoconstriction as a Compensatory Response:
   The body perceives this drop in effective volume as a sign of shock and activates the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS). These systems work to constrict blood vessels, including those in the kidneys, to increase blood pressure and maintain perfusion to vital organs.
3. Impaired Autoregulation:
   In normal kidneys, the blood vessels can automatically adjust their diameter to maintain a consistent blood flow even when overall blood pressure changes. However, in hepatorenal syndrome, this autoregulation is impaired, leading to a more pronounced and sustained vasoconstriction.
4. Consequences of Reduced Blood Flow:
   The narrowed blood vessels in the kidneys restrict blood flow, leading to reduced glomerular filtration rate (GFR) and impaired kidney function. This can lead to a buildup of waste products in the blood and fluid retention.
   In essence, the liver disease and associated circulatory changes in hepatorenal syndrome trigger a cascade of events that ultimately result in reduced blood flow to the kidneys and impaired kidney function.